Literature DB >> 20161877

Notes on the microbiology of cholesteatoma: clinical findings and treatment.

F Ricciardiello1, M Cavaliere, M Mesolella, M Iengo.   

Abstract

Anomalous proliferation of the cholesteatoma epithelium is caused by extrinsic factors such as toxins or bacterial antigens combined with lytic enzymes, lymphokines and cytokines released from the inflammatory infiltrate. This could explain the close relationship between the aggressiveness of cholesteatoma and repeated bacterial superinfection, therefore it is very important to know the bacteria involved in order to control the regrowth of skin following surgery, reduce the aggressive potential of the cholesteatoma and limit the incidence of complications. This study focused on 70 females and 80 males aged between 15 and 65 years, affected by cholesteatomatous otitis media; all underwent bacteriological examination of the auricular secretion. The floral bacteria which proved to play the most important role (60.3%) were the aerobic type and the highest levels were those of Pseudomonas aeruginosa (31.1%) followed by Staphylococcus aureus (19.1%), Proteus mirabilis (7.7%), Escherichia coli (1.4%) and Klebsiella pneumoniae (1%). Anaerobic floral bacteria were found in a fairly high percentage of cases (38.2%); in particular, anaerobic gram-positive cocci (Peptococcus 12.4% and Peptostreptococcus in 4.8% of cases), Bacteroides (12.4%), Clostridium (3.8%), Fusobacterium (2.9%) and Propionobacterium (1.9%) were isolated. In 3 cases of mycetes (1.4%) only Aspergillus, in association with Pseudomonas and Staphylococcus, was identified. The study showed, then, how effective second generation fluoroquinolones and third generation cephalosporins are (the latter being used in pre-adolescent children), the reason being that these antibiotics work not only on Pseudomonas and Staphylococcus, but also on the anaerobic bacteria.

Entities:  

Keywords:  Antibiotics; Cholesteatoma; Chronic otitis; Microbiology

Mesh:

Substances:

Year:  2009        PMID: 20161877      PMCID: PMC2816367     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  22 in total

1.  Microbiology and management of chronic suppurative otitis media in children.

Authors:  I Brook
Journal:  J Trop Pediatr       Date:  2003-08       Impact factor: 1.165

2.  [Microorganisms isolated from chronic suppurative otitis media and their antimicrobial sensitivities].

Authors:  A D Dinçer; A Tekeli; S Oztürk; S Turgut
Journal:  Mikrobiyol Bul       Date:  1992-04       Impact factor: 0.622

Review 3.  Immune involvement in wound healing.

Authors:  A Barbul; M C Regan
Journal:  Otolaryngol Clin North Am       Date:  1995-10       Impact factor: 3.346

4.  Bacteriological study of chronic suppurative otitis media.

Authors:  M V Rao; P A Jayakar
Journal:  J Indian Med Assoc       Date:  1980-07-16

5.  Antibiotics in chronic suppurative otitis media: a bacteriologic study.

Authors:  R Indudharan; J A Haq; S Aiyar
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-05       Impact factor: 1.547

Review 6.  Treatment of cholesteatoma and retraction pockets.

Authors:  J Sadé
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

7.  Bacteriology of intracranial abscess in children.

Authors:  I Brook
Journal:  J Neurosurg       Date:  1981-04       Impact factor: 5.115

Review 8.  The role of anaerobic bacteria in otitis media: microbiology, pathogenesis, and implications on therapy.

Authors:  I Brook
Journal:  Am J Otolaryngol       Date:  1987 Mar-Apr       Impact factor: 1.808

Review 9.  [Role of perimatrix fibroblasts in development of acquired middle ear cholesteatoma. A hypothesis].

Authors:  C Milewski
Journal:  HNO       Date:  1998-05       Impact factor: 1.284

10.  [Basic fibroblast growth factor (b-FGF) in the perimatrix of cholesteatoma].

Authors:  C Milewski; A Fedorowski; A C Stan; G F Walter
Journal:  HNO       Date:  1998-09       Impact factor: 1.284

View more
  15 in total

Review 1.  Innate immunity and the role of defensins in otitis media.

Authors:  Mark Underwood; Lauren Bakaletz
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

Review 2.  A review of current progress in acquired cholesteatoma management.

Authors:  Chin-Lung Kuo; Wen-Huei Liao; An-Suey Shiao
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-17       Impact factor: 2.503

3.  Effects of high hydrostatic pressure on bacterial growth on human ossicles explanted from cholesteatoma patients.

Authors:  Steffen Dommerich; Hagen Frickmann; Jürgen Ostwald; Tobias Lindner; Andreas Erich Zautner; Kathleen Arndt; Hans Wilhelm Pau; Andreas Podbielski
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 4.  Infectious causes of cholesteatoma and treatment of infected ossicles prior to reimplantation by hydrostatic high-pressure inactivation.

Authors:  Wycliffe Omurwa Masanta; Rebecca Hinz; Andreas Erich Zautner
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 5.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

6.  Stem cells in middle ear cholesteatoma contribute to its pathogenesis.

Authors:  Julia Nagel; Saskia Wöllner; Matthias Schürmann; Viktoria Brotzmann; Janine Müller; Johannes Fw Greiner; Peter Goon; Barbara Kaltschmidt; Christian Kaltschmidt; Holger Sudhoff
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

7.  Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

Authors:  Anders Britze; Rune Isak Dupont Birkler; Niels Gregersen; Therese Ovesen; Johan Palmfeldt
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

Review 8.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

9.  TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation.

Authors:  Huaili Jiang; Yu Si; Zhuohao Li; Xi Huang; Suijun Chen; Yiqing Zheng; Guo Xu; Ximing Chen; Yubin Chen; Yi Liu; Hao Xiong; Qiuhong Huang; Maojin Liang; Zhigang Zhang
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

10.  Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS.

Authors:  Matthias Schürmann; Johannes F W Greiner; Verena Volland-Thurn; Felix Oppel; Christian Kaltschmidt; Holger Sudhoff; Barbara Kaltschmidt
Journal:  Cells       Date:  2020-01-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.